Chronopin: upcoming release dates, events and other important dates

The FDA approved Abbott's Volt pulsed field ablation system, a balloon-in-basket catheter that maps, paces and ablates, to treat paroxysmal and persistent atrial fibrillation. The approval rested on the 392-patient VOLT-AF IDE study at 40 centers.

A Baltimore City jury awarded Cherie Craft $59.84 million in compensatory and $1.5 billion in punitive damages, finding J&J's talc baby powder exposed her to the asbestos behind her peritoneal mesothelioma - the largest talc verdict for a single plaintiff. J&J said it would appeal.

The U.S. Pipeline and Hazardous Materials Safety Administration issued an emergency special permit for segments 324 and 325 of the interstate Santa Ynez Pipeline System, approving Sable Offshore's enhanced integrity management practices and setting operational conditions. It is a step toward restarting the onshore transportation that has kept Sable's restarted Santa Ynez Unit oil in storage rather than on sale.

The Undead Unluck anime confirmed a second season the same night its Winter Arc special aired, with a new illustration from creator Yoshifumi Tozuka.

Cloud Art streams Sword of Coming 2nd Season, continuing the donghua about an ordinary boy who splits the sky with a single sword and becomes a legendary swordsman after felling a peerless rival.

Pure Arts' Beyond Time's Gaze begins release, a Chinese donghua following Xu Qing, the sole survivor of the ruined Nanhuang Continent, as a mysterious purple crystal starts him on a cultivation journey and into the Thunder Squad's ranks.

The integrated transport hub at the Beijing City Sub-centre, under Tongyun Subdistrict in Tongzhou District, took its first passengers on the Beijing-Tangshan and Beijing-Binhai intercity railways, with an interchange to Subway Line 6 at Beiyunhedong. Construction of the hub started on 30 November 2019.

A-1 Pictures' Kaguya-sama: Love is War -Stairway to Adulthood- premieres as a TV special, revisiting Kaguya Shinomiya's memories of her Shuchiin Academy student council days with Miyuki Shirogane.

A small Filipino tasting-menu restaurant on Nob Hill, with chef Patrick Gabon in an open kitchen and Celine Wuu running wine and the room.

Jamestown's $500 million overhaul of the long-vacant One Times Square, home of the New Year's Eve ball drop, wrapped up with a new glass facade, museum and observation deck.

There's No Freaking Way I'll Be Your Lover! Unless… ~Next Shine~ premieres on Japanese television, continuing studio MOTHER's light-novel adaptation about a reinvented high schooler juggling confessions from two of her school's most popular students.

A new theatrical anime film of Wandering Witch: The Journey of Elaina is announced, bringing Jougi Shiraishi's traveling witch Elaina back to the screen for the first time since C2C's 2020 TV series.

A second season of The Brilliant Healer's New Life in the Shadows, about an exiled slum-born healer who opens an underground clinic, was announced during the GA FES 2026 livestream.

Ikoku Nikki premieres, a Shuka-animated drama adapting Akane Torikai's manga about a reclusive novelist who unexpectedly becomes guardian to her orphaned teenage niece.

Boston Dynamics revealed the product version of its fully electric Atlas humanoid at Hyundai's CES media day and began building it at its Boston headquarters immediately. Every 2026 Atlas is already committed, with fleets going to Hyundai's Robotics Metaplant Application Center and to Google DeepMind.

Miami-Dade County and Royal Caribbean Group broke ground on a $345 million single-berth cruise terminal able to process about 7,000 passengers per ship call, with a multi-level garage and a ground-level intermodal hub, sized for Icon-class ships. Demolition of the terminal that stood on the site began in July 2025 and the new complex is slated for completion in late 2027.

Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.